Trials / Completed
CompletedNCT00803517
Comparison of Multifocal Electroretinogram Assessment in Chronic Central Serous Chorioretinopathy (CSC) Between Laser Treatment Group and Photodynamic Therapy Group in Chronic Central Serous Chorioretinopathy
Comparison of Multifocal Electroretinogram Assessment Between Laser Treatment Group and Photodynamic Therapy Group in Chronic Central Serous Chorioretinopathy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 24 (actual)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study is a comparison of multifocal electroretinogram assessment between the laser treatment group and the photodynamic therapy group in chronic central serous chorioretinopathy.
Detailed description
1. Laser Group: extrafoveal focal leakage on FAG 2. PDT Group: no definite focal leak on FAG subfoveal or juxtafoveal focal leakage on FAG, or serous retinal pigmentary epithelial detachment involving foveal center Inclusion criteria 1. Chronic serous chorioretinopathy (over 3 months) when subretinal fluid persisted in the subfoveal region demonstrated by clinical examination and OCT 2. Ability to maintain steady fixation for mfERG 3. Presence of abnormal dilated choroidal vasculature in ICGA 4. Symptom duration over 3 months Exclusion criteria 1. previous PDT or laser treatment history 2. evidence of Choriinal neovascularization in FAG 3. other chorioretinal disorders that can cause macular exudation such as age-related macular degeneration, pathologic myopia, angioid streaks, trauma, inflammatory diseases, retinal vasculopathies, and hereditary dystrophies follow-up Visit 1)baseline 2)1month 3)3months 4)6 months each visit: multifocal electroretinogram, visual acuity, optical coference timography should be measured.
Conditions
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2008-10-01
- Completion
- 2008-10-01
- First posted
- 2008-12-05
- Last updated
- 2009-03-12
- Results posted
- 2008-12-05
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00803517. Inclusion in this directory is not an endorsement.